A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD5148 in Healthy Adults

Trial Identifier:	D8820C00002
Sponsor:	AstraZeneca
Start Date:	June 2024
Primary Completion Date:	February 2025
Study Completion Date:	November 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, AL	Anniston, AL, US, 36207
US, CA	Glendale, CA, US, 91206
US, MD	Baltimore, MD, US, 21225
US, TX	San Antonio, TX, US, 78229

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.